Main effect | Result |
Reduced hepatic FFA supply | ↓ TAG synthesis |
↓ Hepatic insulin resistance | |
↓ Hepatic glucose output | |
↓ ROS generation | |
↓ Hepatocyte inflammation | |
Improved extrahepatic insulin sensitivity | ↓ De novo lipogenesis (↓SREBP-1) |
→ reduced circulating insulin levels | ↑ VLDL export |
↓ Fibrosis | |
↓ Adipose tissue inflammation | ↓ Pro-inflammatory cytokines |
↑ Leptin sensitivity (↓SOCS-1) | |
↑ Adiponectin |
FFA, free fatty acid; ROS, reactive oxygen species; SOCS, suppressor of cytokine signalling; SREBP, sterol regulatory element-binding protein; TAG, triacylglycerol;VLDL, very low-density lipoprotein.